Clinical Trials on Coxsackievirus Infections

Total 56859 results

Vancouver Island Health Authority

Unknown

Lyophilized Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection

Clostridium Difficile Infection

Canada
National Taiwan University Hospital

Completed

Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection

Helicobacter Pylori Infection

Taiwan
Merck Sharp & Dohme LLC

Completed

A Study of MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001) (MODIFY I)

Clostridium Difficile Infection
Mackay Memorial Hospital

Completed

Intraluminal Therapy for Helicobacter Pylori Infection

Helicobacter Pylori Infection

Taiwan
Queen Elizabeth II Health Sciences Centre

Unknown

Fecal Microbiota Therapy for Recurrent Clostridium Difficile Infection

Clostridium Difficile Infection
Southwest Oncology Group
University of Michigan; Hope Foundation

Completed

S1119 Peruvian H. Pylori Water Contamination Study

Helicobacter Pylori Infection

Peru
Barts & The London NHS Trust

Unknown

Novel Biomarkers to Predict Outcome in Clostridium Difficile Infection

Clostridium Difficile Infection

United Kingdom
Samsung Medical Center

Unknown

Randomized Study on Efficacy of Gemifloxacin-based Regimen for Helicobacter Pylori Infection

Helicobacter Pylori Infection

Korea, Republic of
Massachusetts General Hospital

Completed

Fecal Microbiota Transplant (FMT) for Relapsing C. Difficile Infection in Adults and Children Using a Frozen Inoculum

Clostridium Difficile Infection

United States
Medical College of Wisconsin

Withdrawn

Treatment of C. Difficile Infection With Fecal Microbiota Transplantation (FMT)

Clostridium Difficile Infection

United States
Seoul National University Bundang Hospital
Ministry of Education, Republic of Korea (2012R1A1A3A04002680)

Completed

15-day Sequential Therapy for Helicobacter Pylori Infection in Korea

Helicobacter Pylori Infection

Korea, Republic of
Catholic University of the Sacred Heart

Unknown

Efficacy of Acetilcysteine in 'Rescue' Therapy for Helicobacter Pylori Infection. Pilot Study

Helicobacter Pylori Infection

Italy
Pfizer

Completed

An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current Therapy

HIV Infections | Mycobacterium Avium-Intracellulare Infection

United States
Pfizer

Completed

A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients

HIV Infections | Mycoses | Mycobacterium Avium-Intracellulare Infection

United States
University of Oxford

Completed

The Microbiology of Pleural Infection (TORPIDS)

Pleural Infection | Pleural Infection Bacterial

United Kingdom
University Hospital, Clermont-Ferrand
Centre Leon Berard; Centre Jean Perrin; University Hospital, Grenoble; Hôpital... and other collaborators

Unknown

Randomized, Multicenter, Double-blind, Vancomycin-controlled Study to Evaluate the Efficacy of Ethanol Lock Solution for the Curative Treatment of Implantable Venous Access Port Infection Due to Coagulase-negative Staphylococci (Etha-LOCK)

Catheter Related Blood Stream Infections | Intravenous Drug Delivery Systems | Lock Solution | Central Venous Catheter Infection | Coagulase-negative Staphylococci Infection

France
HaEmek Medical Center, Israel

Unknown

Safety and Tolerability of Herpes Zoster Vaccine Rheumatologic Patients

Herpes Zoster

Israel
GlaxoSmithKline

Completed

Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers

Herpes Zoster

France, Spain, Taiwan, Belgium, Singapore, United States, Hong Kong, Russian Federation, Finland, Korea, Republic of, Czechia, Australia, Canada, Sweden, Poland, United Kingdom, Panama, Italy, Turkey, Pakistan, New Zealand
Copenhagen University Hospital, Hvidovre
University of Copenhagen

Not yet recruiting

Virus as Treatment of C. Difficile Infection (VISION) (VISION)

Clostridium Difficile Infections

Denmark
University Hospital, Rouen

Unknown

Burden of Staphylococcus Lugdunensis Infections in Hospitalized Patients (INHOSTAL)

Staphylococcus Lugdunensis Infection

France
GlaxoSmithKline

Completed

Evaluation of the Immune Response to Clostridium Difficile in Adults With Clostridium Difficile Infection (CDI)

Infections, Clostridium Difficile

United States, Canada
Ann & Robert H Lurie Children's Hospital of Chicago

Completed

Molecular Epidemiology of Clostridium Difficile Infections in Children

Clostridium Difficile Infections

United States
National Research Center for Cardiac Surgery, Kazakhstan
Nazarbayev University Medical Center

Recruiting

Clinical, Functional, Immunological and Genetic Factors on the Severity of the Course of Coronavirus Infection

Covid19 | Corona Virus Infection

Kazakhstan
University Hospital, Basel, Switzerland

Recruiting

A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System® (CCS)

Cytomegalovirus Infections | EBV | Adenovirus Infection | Cytokine Capture System | Allogenic Disease

Switzerland
Manuel Coelho da Rocha

Not yet recruiting

Tailored vs. Empirical Helicobacter Pylori Infection Treatment

Helicobacter Pylori Infection

Portugal
Shanghai Zhongshan Hospital

Recruiting

Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment

Helicobacter Pylori Infection

China
Second Affiliated Hospital of Xi'an Jiaotong University

Recruiting

Influencing Factors of Helicobacter Pylori Infection and Eradication Failure

Helicobacter Pylori Infection

China
University Hospital Freiburg

Recruiting

Pathogen-microbiome Interaction During Helicobacter Pylori Infection (PREDICTHP)

Helicobacter Pylori Infection

Germany
McGill University Health Centre/Research Institute...
Canadian Institutes of Health Research (CIHR)

Recruiting

Initial Vancomycin Taper for the Prevention of Recurrent Clostridium Difficile Infection (TAPER-V)

Clostridium Difficile Infection

Canada
Hamdard University

Completed

Clinical Efficacy and Safety Assessment of Alsareen Capsule for the Management of H. Pylori Infection

H. Pylori Infection

Pakistan
Crestone, Inc
National Institute of Allergy and Infectious Diseases (NIAID)

Active, not recruiting

Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection

Clostridioides Difficile Infection

United States, Canada
Hellenic Institute for the Study of Sepsis

Completed

Addressing Personalized Needs in Clostridioides Difficile Infection (BEYOND)

Clostridioides Difficile Infection

Greece
TenNor Therapeutics (Suzhou) Limited

Completed

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TNP-2198 Capsules in Asymptomatic Participants With Helicobacter Pylori Infection

Helicobacter Pylori Infection

China
Summit Therapeutics
Department of Health and Human Services

Terminated

Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects (Ri-CoDIFy 3)

Clostridioides Difficile Infection

United States
Centre Hospitalier Universitaire, Amiens

Completed

Nosocomial Outbreak of BHRe in an Intensive Care Unit During SARS-CoV-2 Pandemic (BHReICU)

Enterobacteriaceae Infections | Hospital-Acquired Infection

France
University of Virginia

Terminated

Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection

Clostridium Difficile Infection

United States
University Hospital, Basel, Switzerland
propatient foundation Basel

Completed

Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus Aureus (TARGET II)

Staphylococcus Aureus Infection

Switzerland
University of Leeds
GlaxoSmithKline; AstraZeneca; Sanofi Pasteur, a Sanofi Company; BioMérieux; Da Volterra and other collaborators

Completed

COMBACTE-CDI Understanding the Burden of C. Difficile Infection (COMBACTE-CDI)

Clostridium Difficile Infection

United Kingdom
Janssen Vaccines & Prevention B.V.
Bavarian Nordic

Terminated

Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix

Human Papillomavirus Infections

United States, Belgium
Federal State Budgetary Scientific Institution...
St. Petersburg State Pavlov Medical University; Moscow Clinical Scientific... and other collaborators

Completed

Helicobacter Pylori Infection Occurrence in Russia

Helicobacter Pylori Infection

Russian Federation
Antonio Mestrovic
University Hospital of Split; University of Split, School of Medicine

Completed

Comparison of Therapy in Treatment of Patients With Helicobacter Pylori Infection: Concomitant Versus Hybrid Therapy.

Helicobacter Pylori Infection

Croatia
University of Erlangen-Nürnberg Medical School

Completed

Immediate Detection of Helicobacter Infection With a New Electrochemical System.

H. Pylori Infection

Germany
Mayo Clinic
Rebiotix Inc.

Completed

Treatment of Recurrent Clostridium Difficile Infection With RBX7455

Clostridium Difficile Infection

United States
University of Split, School of Medicine

Completed

Quadruple vs Tailored Therapy in the Treatment of Helicobacter Pylori Infection

Helicobacter Pylori Infection

Croatia
Oslo University Hospital
University of Oslo

Terminated

IMT for Primary Clostridium Difficile Infection

Clostridium Difficile Infection

Norway
National Taiwan University Hospital

Completed

Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection

Helicobacter Pylori Infection

Taiwan
Hospital Universitario de Cabuenes
Merck Sharp & Dohme LLC; Hospital Universitario Central de Asturias; Instituto...

Unknown

PROSPECTIVE STUDY OF PREDISPOSING FACTORS OF REFRACTARY Clostridium Difficile INFECTION. INFLUENCE OF THE GUT MICROBIOMA

Clostridium Difficile Infection
Ayman Magd Eldin Mohammad Sadek

Completed

Comparison Between Quadruple Regimens for Helicobacter Pylori Infection in Egypt

Helicobacter Pylori Infection

Egypt
Kaohsiung Veterans General Hospital.
Kaohsiung Medical University Chung-Ho Memorial Hospital

Completed

Comparison of Two Rescue Therapies for Helicobacter Pylori Infection

Helicobacter Pylori Infection

Taiwan
Merck Sharp & Dohme LLC

Completed

A Study of MK-6072 and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-002) (MODIFY II)

Clostridium Difficile Infection

Clinical Trials on Coxsackievirus Infections

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations